Stephen Swisher

22PUBLICATIONS
138CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersLiquid biopsiesRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Oct 09, 2024
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.

Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do

|Mar 17, 2023
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial.

Tina Cascone, Cheuk H Leung, Annikka Weissferdt

|Jan 30, 2023
Benchmarking Outcomes for Molecularly Characterized Synchronous Oligometastatic Non-Small-Cell Lung Cancer Reveals EGFR Mutations to Be Associated With Longer Overall Survival.

Brian De, Ahsan S Farooqi, Kyle G Mitchell

|Sep 13, 2022
The Single-Cell Immunogenomic Landscape of B and Plasma Cells in Early-Stage Lung Adenocarcinoma.

Dapeng Hao, Guangchun Han, Ansam Sinjab

|Apr 08, 2022
Distinct Immune Gene Programs Associated with Host Tumor Immunity, Neoadjuvant Chemotherapy, and Chemoimmunotherapy in Resectable NSCLC.

Pedro Rocha, Jiexin Zhang, Raquel Laza-Briviesca

|Apr 05, 2022
MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers.

Omar Alhalabi, Jianfeng Chen, Yuxue Zhang

Pageof 4

Frequent Collaborators

16 joint publications

John V Heymach

14 joint publications

Jack Lee

9 joint publications

Edwin Roger Parra

7 joint publications

Jianjun Zhang